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It h as been suggested that glucocorticoids p roduce their 
biologic effects throug h the synthesis of phospholipase A2 
inhibitor pro tein (lipocortin) in various cell systems. Recent 
studies from our laboratory revealed that glucocorticoids 
au g m ent the f3-adrenergic adenylate cyclase response of 
epidermis and that this effect depends on a protein synthesis 
m e chanism. In order to elucidate the possible mechanism 
of this glucocorticoid effect in terms of phospholipase A2 
activity, an in vitro pig skin incubation system was em-
ployed. M epacrine, a phospholipase A2 inhibitor, aug-
m e nted the f3-adrenergic adenylate cyclase response of ep-
ide rmis as glucocorticoids. The effect o f mepacrine was 
s tronger and w as observed earlier than that o f glucocor-
ticoid (hydrocortisone). The addition o f both m epacrine 
and hydrocortisone at their optimal concentrations in the 
I t has been suggested that g lll cocorti coids produce their bi-ologic effects through the synthesis of PhOS PI.lOlipase A2 (PLA2) inhibito r pro tein (lipocortin *) in various cell sys tem s [1-51· Since PLA2 is one o f the key enzy m es fo r release of arach-idoni c acid (AA) from m embrane phospholipids, and since 
AA is a precursor o f va rious infl ammato ry m ediato rs (6), the anti-
inflammatory effect of glucocorticoids has been attributed to the 
synthesis of lipocortin [1-3]. The question of whether epiderm al 
k e ra tinocytes synthesize lipocortin by g lucocorticoid t reatment 
re m ains unkno wn at present. 
Previously we have shown that pig epidermal .a-adrenergic 
ad e nylate cyclase g radually loses its ca techolamine sensitivity dur-
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incubation m edium, resulted in neither an additive no r a 
synergistic effect on the f3-adrenergic aug m entation. O n 
the o ther hand , m elittin , a phospholipase A2 stimulato r, 
depressed the f3-adrenergic adenylate cyclase response. T he 
addition o f both melittin and hydrocorti sone in the in cu-
bation m edium resulted in the inhibition of the hydrocor-
tisone-induced f3-adrenergic aug mentatio n effect. Follow-
ing long-term incubation with hydrocortisone, the epidermal 
phospholipase A2 activity was significantly decreased. T hese 
results indicate that g lu cocorticoids might affect the f3-ad-
renergic adenylate cyclase response of epidermis through 
the synthesis of phospholipase A2 inhibito r protein (lipo-
cortin) as in o ther cell system s. J In vest D en'l'lato/ 87:577-
581, 1986 
in g long-term inCL1bation in vitro, and that the addi tion of glu-
cocorticoids in the in cuba tion m edium prevents or rather aug-
m ents this receptor response [7, 8]. Further, it was found that 
va rio us pro tein synthesis inhibi to rs produced an inhibito ry effect 
on this glucocorti coid effect [7] as welJ as a " paradoxical" 
.a-adrenergic aug mentati on effect (9), bo th of w hich are consistent 
wi th the findin g of a classical stero id-induced pro tein induction 
m odel [1 0]. Thus it was sugges ted that g lucocorti coids mig ht 
produce their effects through the synthesis of a specific protein 
in epidermis, res ultin g in the .a-adrenergic aug m entatio n effect 
[7-9]. T he nature of this g lucocorticoid-induced protein , how-
ever, rem ains unknown at present. 
Adenylate cyclase is a membrane-bound enzyme co mplex, the 
activity of w hich is known to be m odulated by a m odifica tion of 
m embranous phospholipid environments. For exa mple, phos-
phatidy lcho line (PC), w hich appea rs to be the m ajor substra te of 
epiderm al PLA2 [11-1 3], prom otes o r is required fo r stimul ation 
of adenylate cyclase (14) . Interes ting ly, lyso PC (the degradation 
product of P C by PLA2) cannot substitute fo r PC in this respect 
[14] . Further, a direct inhibi to ry effect of lyso PC [1 5] as well as 
free fa tty acids (ano ther degradation product of PC by PL A2) [1 6] 
on adenylate cyclase activity has been reported in several cell 
systems. These co rrel ations pro mpted liS to stud y the effect of 
glucoco rticoids 0 11 the .a-adrenergic system of epidermis in term s 
of PLA2 m odulation. 
MA T E RIALS AND METH ODS 
T he experim ental procedures used were essentially the sa m e as 
those previously described [7] . D o m estic pigs weighing 5- 10 kg 
were an esthetized i. p . with N embu ta l (dose 30 m g/kg; Abbo tt 
Laborato ries, N orth C hicago, Illinois). Fifteen minu tes after the 
0022-202X/86/S03.50 Copyright © 1986 by The Society fo r Inves tiga tive Dermatology, Inc. 
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anesthes ia, skin slices were taken from the backs o f th e pi gs by 
use o f a Castroviej o kerato m e (Storz In strument Co., St. Louis, 
Missouri) set at a 0 .2-mm depth . As skin sli ces thus o btained 
contain mainly epidermis (80- 90% ) [17], these are ca lled "epi-
dermal " sli ces. The epiderm al slices were th en cut into 5 X 5 
mm squares, washed 3 tim es in RPMI 1640 medium , and the 
skin squares w ere fl oa ted w ith their keratin layers up in RPMI 
1640 medium with added antibio ti cs (100 U / ml penicillin , 0.1 
m g/ml strepto m ycin , 0. 25 J.Lg/ml Fun gizone) and various chem-
icals to be tested . T he incubations we re done at 3rC in an atIn os-
phere of 5% CO2 in air fo r th e indi ca ted tim e. Fo llowin g th e 
incubation , epinephrine-induced cyclic AMP accumulations o f 
skin squares w ere determined as previ ously described [7 ,8] using 
a Yamasa cyclic AMP assay kit (Yamasa Shoyu Co., Tokyo). 
The measurement of PLA 2 activ ity w as based on th at o f Frein-
kel and Traczyk [1 8]. Following th e incubation with vari ous 
chemicals, skin squ ares were frozen between 2 dry-i ce plates . The 
samples w ere th en homogeni zed with a g lass homogenizer in 1 
ml 0.25 M sucrose per 10 skin squ ares at 4°C. The homogenate 
w as centrifuged at 15,000 g fo r 10 min at 4°C and the supernatant 
was used as an enzym e source. Phos pholipase A2 activity was 
determined radio chemically; the reaction mix ture contained 0.05 
M glycine-NaO H buffer (pH 8.5), 1 mM CaCI2, 0. 63 nmol (20,000 
cpm) of I-palmitoyl-2-[1-1 4 C]-arachid onyl-g lycero-3-phos pho-
choline and 50- 100 J.Lg protein o f the 15,000 g supern atant in a 
fin al volume of 0.2 1111. The incubations were ca rried out at 3rC 
for 1 h. Incubati ons were also perform ed using a reagent mix ture 
containin g 5 mM ·ethyleneglyco ltetraa ceti c acid (EGTA) (instead 
oflmM C aC h) and the difference in radioactivity o f released AA 
(vide infra) was interpreted as th e epiderm al PLA2 activity. Fo l-
lowing the incubation , lipids w ere extracted by th e meth od o f 
Bligh and D yer [1 9] and applied to Silica Gel 60 F25'1 thin-layer 
plates with AA as the m arker, and were developed with ethyl 
acetate: g lacial ace ti c acid (99:1 , v/v) . The spo ts were made visib le 
in iodin e vapor and th e zone correspondin g to A A was counted 
fo r radioactivity. T he reaction was linear fo r at least 90 min and 
the release o f AA from PC was less than 15% in our system . 
Although the release o f AA from PC is ass umed to be medi ated 
throu gh PLA2 [11- 13], PC deg radation mi ght also be medi ated 
by phospholipase C, (PLC) path wa y. Sin ce the eth yl acetate/ 
glacial acetic acid system does no t separate AA from diacylg ly-
cerol (product ofPLC), another thin- laye r separati on system was 
employed . Thin-layer plates w ere developed with isopropyl-
ether: glacial acetic acid (96 : 4, v/ v) to two-thirds o f th e plate and 
then with petrolatum ether:diethylether: glacial ace tic acid (90:10: 1, 
v/ v/v) . The radioactivity of di acylg lycerol w as less than 20% of 
the released AA (data no t shown) . The results are consistent w ith 
the current v iew th at the m aj o r substrate of PLC is phosphati-
dylinositol lipids [20) and it w as concluded that AA released in 
our system w as m ainly medi ated by PLA2 . 
Protein concentrati on was meas ured by th e method of Lowry 
et al [21] . The statistical signifi cance of th e data obtained w as 
evaluated by Student' s I-tes t . 
RPMI 1640 m edium w as purchased from GIBCO (Grand Is-
T H E JOUHNAL O F IN VESTIGATIVE DEHMATO LOGY 
land, N ew York) and from Biken (Osa ka) . Peni cillin-strepto-
m ycin-Fungizone mi x ture w as obtained from M. A. Bioproducts · 
(Walkersvill e, Maryland) . H ydroco rtisone and m epacrine (quin-
acrine dih ydrochloride) were purchased fro m N akarai C hemicals 
Ltd . (Kyoto). Melittin w as purchased from Sigm a C hemical Co. 
(St. Louis, Misso uri ). I-Palmitoyl-2-[V"C]-arachidonyl-g ly-
cero-3-phosphocholine (sp act 52.9 IllC i/ mmol) was obtained fron, 
N ew England Nuclear (Bos ton, Massachusetts). Silica gel 60 F254 
thin-la yer pl ates were purchased fro m Merck (Darmstadt , West 
Germany). Arachidoni c acid as the marker w as obtained from 
Sigm a. All o ther chemi ca ls were purchased fro m Nakarai C hem-
icals Ltd . 
RESULTS 
The effect o f m epacrin e and hydrocorti sone on th e f3-adrenerg ic 
adenylate cyclase response of epidermis is shown in Table I. Dur-
ing the long-term incubation in vitro , th e f3-adrenerg ic response 
of epidermis g raduall y decreased. The addition of hydrocortisone 
prevented thi s decrease o r rath er aug mented the ,B-adrenerg ic 
response of epidermis. These results are consistent with our pre-
vious repo rts [7- 9]. The addition o f m epacrin e, a PLA2 inhibitor 
[23], in the in cubation medium markedly au gm ented the f3-ad-
renergic response o f epidermi s (T able I) . The effe ct o f mepacrine 
was concentration-depend ent and th e mos t marked effect w as 
observed at 100 J.LM (data no t shown). At optimal concentrations, 
th e m epacrin e effect w as stronger th an th at o f hydrocortisone. 
Further, the effect o f mepacrine appeared earlier th an th at of 
hydrocortisone; th e m epacrine effect was observed at 2-h incu-
bation, w hereas the h ydrocortisone effect w as no t apparent until 
6-h incubation . M epacrine alo ne had no effect on the basal cyclic 
AMP level o f epidermis (data no t shown). The addition of m e-
pacrin e at the tim e of epinephrine ac tivation did not influence the 
epinephrine-induced cycli c AMP accumulation o f epidermis (Ta-
ble I, O-h incubati on) . Since th e m os t m arked f3-adrenergic aug-
mentation effect w as observed at 6-24 h in cubation by mepacrine 
treatment and at 24-48 h in cubation by hydrocortisone treatment, 
respectively, the combination experim ent was performed using 
24-h incubation tim e. The addition o f bo th m epacrine and hy-
drocortisone in the long-term incubati on medium resulted in nei-
ther an additive no r a syn erg istic ,B-adrenergic aug mentation effect 
(Table I, 24-h incubation) . 
The effect of mclittin , a PLA2 stimu lato r [24], and its relation 
to hydrocortisone effects are shown in T able" and Fig 1. Melittin 
alone had no effect on th e basal cycli c AMP level of epidermis 
(data not shown) . The addition o f m elittin at the time of epi-
nephrine ac tivation had no signifi cant effect o n th e f3-adrenerg ic 
response o f epidermi s (Table II , O-h incubation). However, ep-
idermis trea ted w ith mclittin fo r 2 h revea led a signifi cant decrease 
o f th e f3-adrenergic res ponse o f epidermis (Table II , 2-h incu-
bation) . Since the f3-adrenergic response o f control epidermis also 
decreased durin g long-term incubation, the differen ce between 
contro l and Ill elittin-trea ted epidermis was no lon ger observed at 
24-h incubation time (Table II, 24-h in cubation) . 
The additi on of mclittin in th e in cubation medium markedl y 
Table I. Effect o f Mepacrine and Hydroco rti sone on the f3-Adrenergic Adenylate Cyclase Response of Epidermis 
In cubation Time Control Mepacrine Hydrocortisone Both 
o h 6.6 ± 0.5 6.0 ± 0.5 ND ND 
2 h 4.8 ± 0.5 13.6 ± 1. 0" 6.6 ± 0.8 NO 
6 h 3.8 ± 0.2 19.2 ± 1.lh 5.6 ± 0.6" NO 
24 h 3.3 ± 0.2 23 .1 ± 2.4h 10.4 ± 1. 3/' 25 .4 ± 3.6/' 
Pig skin squares we re incubated w ith 100 J.L M rn cpa crinc. 100 J.LM hydrocortisone. o r bo th CO TllpoUllds for indiGltcd t irnc. H yd rocortisone w as dissolved ill ethanol and 
the fina l co ncentrati o n of ethano l w as 0.5% v/v. Fo ll owin g the in cuba tio n, skin squ ares were in cubated w ilh 50 J-tM epine phrin e fo r 5 min and the cycli c AMP level in skin 
sq uares was determin ed . Data arc ex pressed as cycl ic AMP pmol/ lll g prote in ± SE (n = 6 rro lll 2 independent ex perilll ental series). Signifi ca nce o rtlle result·s was determined 
com pa red w ith the control va luc or c:1ch incubatio n tim e. The b :1 sall evcl s of cycli c AMP w ith o ut the additi o n o f epine phrin e we re all aro lilld I pm o l/ 11l g pro te in. In cubation 
at 0 ho urs was done fo ll owin g 20-min pre in cubat io n at 37°C to standardize the cycli c AMP level 122 1. Sk ill sq uares w e re in cubated w ith epine phrin e fo r 5 min in the 
presence o r absence or 100 f'M mepacrin e. 
"1' < 0.05. 
/'1' < 0.0 1. 
ND = not determin ed. 
V O L. 87, NO.5 N O VEMI3E R 1986 PH OSPH O LIPA SE A, AN D I3 ET A-ADR EN EnG IC RES PO N SE 579 
Table II. Effect of M elittin and H ydroco rtisone on the f3-Adrenergic Adenylatc Cyclase Responsc o f E pidcrmis 
Incubation T ime Control Melittin Hydrocortisone Both 
Oh 9.6 ± 0.8 8.8 ± 0.8 ND ND 
2 h 4.5 ± 0.3 2.8 ± 0.1" ND ND 
24 h 2.3 ± 0.2 2.2 ± 0. 1 6.4 ± 0.8" 2.0 ± 0. 1/0 
T he ex pel ,mental conditions we re essenti all y the same as in Table I. The concentrations of mcl ittin and hydroco rt isone were 20 J.Lg/ ml and 100 J.LM. respecti vely . Fo llowin g 
th e in cub;1tio J1 w ith various chemicals. epinephrine-induced cycl ic AMP accumulatio ns were d ete rmined . D .a ta arc ex pressed as cycl ic AMP pmol/ lll g pro tein ± SE (11 = 
6 fro m 2 independent cXpCri1TICiltai series). Signi fica nce o f the results was determined co mpared w ith th e control va lue of each incubatio n rime. 
' p < 0.0 1. 
' N o t signifi cant compared w ith contro l (p > 0.2), but highly signifi cant co mpared w ith hydroco rtisone-trea ted epidermis (1' < 0.0 1). 
ND = no t determined . 
d ecreased the hydrocortisone-induced f3-adrenerg ic au gmentation 
effect at 24-h incubation (Table II , 24-h incubation; Fig 1) . The 
inhibitory effect of melittin on the hydrocortisone effect w as con-
centration-dependent. When 100 /LM hydrocortisone was used to 
induce f3-adrenerg ic augmentation, the half inhibitory effect w as 
observed at around 4 /Lg/ml of melittin (Fig 1). At 40 
J,Lg/ml concentration, the f3-adrenergi c response w as completely 
abolished (Fig 1) . 
Table III shows the effect of hydrocortisone on the PLA2 ac-
ti v ity of epidermis. Following 24-h incubation with hydrocor-
tisone, epidermal PLA2 activity w as significantly decreased . The 
inhibitory effect was observed at 1-100 /LM conccntrations. The 
direct addition of hydrocortisone (up to 100 /LM concentration) 
at the time of PLA2 assa y had no effect on the enzyme activity 
(data not shown) . 
DISCUSSION 
Our results suggest that the epidermal f3-adrenerg ic adenylate 
cyclas~ response is modu lated by PLA2 as in other cell systems 
[25]. Mepacrine, a PLA2 inhibitor [23], augmented , and melittin, 
a PLA2 stimulator [24], decreased the f3-adrenerg ic response of 
epidermis (Tables I, II) . Nemoto et al [26] reported that mepacrine 
reversed the f3-adrenergic-induced refractoriness o f pig skin ep-
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Figure 1. Pig skin squares were incubated with 100 ILM hydrocortisone 
in the presence of various concentrations of melittin . Following 24-h 
incubation in vitro, the f3-adrenergic response of epidermis was deter-
mined as in Table I. A, epinephrine response of control epidermis (neither 
hydrocortisone nor melittin was added in the incubation medium). B, 
epinephrine response of hydrocortisone-treated epidermis (melittin was 
not added in the incubation medium) . The basal levels of cyclic AMP 
without the addition of epinephrine were all around 1 pmol/mg protein. 
n = 4 from a typical experimental series . Bars, SE. 
idermis. In our stud y, m epacrine treatm cnt alone (without the 
initial induction of refractorincss) w as shown to augmcnt thc f3-
adrenerg ic res ponse in vitro (T able 1). N emoto et al [27] also 
reported that PLA2 m odulation affec ts thc ischemia-induccd rise 
o f cycli c AMP in vivo; mepacrine increascd and m elittin decreased 
the effect o f ischemia. Since the cffect of ischemia recentl y w as 
found to be th e f3-adrenerg ic adenylate cyclase activati on of ep-
idermis [28], their results should now be interpreted as the m od-
ulation o f the f3-ad renerg ic response by mcpacrin e and melittin 
in vivo . T aken togeth er, it is highl y conceivable that PLA2 activity 
modulates epidermal f3-adrcncrg ic response bo th in vivo and in 
vitro. 
Our results furth er sugges t that the effect of glucocorti coids 
on the f3-adrenergic response is m ediated through th e m odulation 
of epidermal PLA2 activity. It has becn suggcsted that g lucocor-
ticoids affect the ,B-adrenerg ic response of epidermis through a 
specific pro tein synthesis m echanism (vidc supra), and it is qui te 
likely that this s teroid-induced pro tein is a PLA2 inhibito r, i.e., 
lipocortin , as in other cell systems [1 - 5] . The combinati on o f 
m epacrine and hydrocortisone at their optimal concentrations re-
sulted in neithcr an additive no r a syncrgistic cffect (Ta ble I), 
suggestin g th at they probably work on thc sa m e site. O n the 
o ther hand , the combination of m elittin and hydrocorti so nc rc-
suIted in the inhibition o f hydrocorti sone-induced f3-adrcnergic 
augmentation effect (Table II , Fig 1) . Finall y epidermal PLA2 
activity was signifi cantl y decreased fo ll owin g 24-h incubation 
with hydrocortisone and the concentration of PLA 2 inhibi tory 
cffect w as similar to that o f the f3-adrenerg ic augmentation eftect 
(T able Ill , [8]) . 
A direct inhibitory effect o f glucoco rticoids on PLA2 ac tivi ty 
has been repo rted by scveral invcs ti gators [29]. H ydrocortisonc 
itsel f, however, had no direct inhibitory effect in our systcm . 
Incubation of epidermis for 6-1 2 h was rcquired fo r thc decrca ed 
PLA2 activity to be detectcd (data no t shown). This is consistent 
with the time-consuming lipoco rtin synthesis mechanism , w hi ch 
also can be appreciated by the findin g th at thc effect of hydro-
cortisone on the f3-adrenergic responsc was no t apparent until 6-h 
incubation , whereas mepacrinc required mllch less timc fo r its 
Table III. Effect of H ydroco rtisone on Epidcrm al 
Phospholipasc A2 Activity 
Control 
0.1 J..tM 
1 J..tM 
10 IL M 
100 J..tM 
Phospholipase A2 Activity 
Released Arachidonic Acid 
(cpm/ mg protein /h) 
4338 ± 34 1 
3771 ± 122 
2572 ± 142" 
2126 ± 108" 
2254 ± 68" 
Pig skin squ ares were incubated w ith various concentrations of hydrocort isone 
(o r 24 h. Fo llowing the incubatio n. skin squares (10 squares each) we re fro zen 
between 2 d ry-icc pl ates. Phospholipase A, act ivity was determincd as described in 
the tex t. Sin ce therc was a ma rked variation in PLA, activity am ong each experi-
m ental series, data fro m a ty pic:d experim enta l series arc showll . Data arc expressed 
as released AA (cpm)/m g pro tein/ It :!: SE (n = 5). 
"1' < 0.01 compared w ith contro l. 
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activity (T able I) . Since the l3-adrenerg ic res ponse of the control 
epidermis g radually d ecreased durin g lon g-term in cubation (Ta-
bl e I, [7,8]) , it is likely that PLA2 ac tivation continuously occurs 
durin g the in cubation of contro l epidermis. Consistent with this, 
Isseroff et al [30] repo rted that fatty acid composition of kerat-
in ocytes alters durin g in vitro culture, suggesting that phospho-
lipid m etabolism is b y no m eans static in in vitro culture condition. 
Thus there was no difference in the f3-adrenerg ic response be-
tween control and melittin-treated epidermis at 24-h in cubation 
(Table II); glu cocorticoids seem to work through lipocortin syn-
thesis m echanism resultin g in the preserved (see [7]) or rather 
in creased l3-ad renerg ic response. 
Recent evidence sugges ts that phospholipid metabolism is mark-
edl y accelerated in various inflammatory conditions of ke-
rat inocytes [6]. Psori asis is a w ell-known exa mple, where PLA2 
activity as w ell as its metabolites such as AA or 12-L-hydroxy-
5,8,10,14-eicosatetraenoic acid (12-HETE), are m arkedly in-
creased [31-34]. Interes tingly the l3-adrenergi c response o f pso-
riatic-involved epidermis is markedly defective [351, which ca n 
be normalized by g lucocorticoid treatment in vivo (Iizuka et aI, un-
published d ata) . Thus the increased PLA2 activity might be 
related to the defective l3-adrenergic response of psoriatic epi-
dermis, where glucocorticoids might normalize the l3-adrenerg ic 
response throu g h PLA2 modulation. In this context, it is inter-
es ting to no te that topical application of glucocorticoids decreased 
epidermal PLA 2 activity (36] as well as AA and 12-HETE content 
[37]. which migh.t be associated with their clinical efficacy on the 
pso riatic epidermi s. The question of how the increased l3-adre-
nerg ic response indu ced by glucocorticoids is associated with their 
clinical efficacy, however , remains unknown at present. 
Finally it must be m entioned that the inhibition ofPLA2 might 
not be the sole m echanism of the l3-adrenerg ic augmentation 
effect . There are several other agents that augment the l3-adre-
nergic response in our system (see [38]) . Ultraviolet B irradiation, 
which apparently activates epidermal PLA2 [39] has been shown 
to augment (not decrease) the l3-adrenergic response in vivo [40] . 
Thus further s tudy is required to elucidate the regulat ry m ech-
anism of th e epidermal l3-adrenergic system . The present study, 
however , sugges ts the possible link between phospholipid and 
cyclic nucleotide m etabolism by g lu cocorticoids in epidermis, all 
of which are known to be important modulators of epidermal 
bio logic activity. 
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